139 related articles for article (PubMed ID: 20553953)
1. The sensitization of peripheral C-fibers to lysophosphatidic acid in bone cancer pain.
Zhao J; Pan HL; Li TT; Zhang YQ; Wei JY; Zhao ZQ
Life Sci; 2010 Jul; 87(3-4):120-5. PubMed ID: 20553953
[TBL] [Abstract][Full Text] [Related]
2. Modulation of Nav1.8 by Lysophosphatidic Acid in the Induction of Bone Cancer Pain.
Pan HL; Liu BL; Lin W; Zhang YQ
Neurosci Bull; 2016 Oct; 32(5):445-54. PubMed ID: 27631681
[TBL] [Abstract][Full Text] [Related]
3. Identification of the sensory nerve fiber responsible for lysophosphatidic acid-induced allodynia in mice.
Ohsawa M; Miyabe Y; Katsu H; Yamamoto S; Ono H
Neuroscience; 2013 Sep; 247():65-74. PubMed ID: 23685168
[TBL] [Abstract][Full Text] [Related]
4. Involvement of lysophosphatidic acid in bone cancer pain by potentiation of TRPV1 via PKCε pathway in dorsal root ganglion neurons.
Pan HL; Zhang YQ; Zhao ZQ
Mol Pain; 2010 Dec; 6():85. PubMed ID: 21118579
[TBL] [Abstract][Full Text] [Related]
5. Profiling of BoNT/C3-reversible gene expression induced by lysophosphatidic acid: ephrinB1 gene up-regulation underlying neuropathic hyperalgesia and allodynia.
Uchida H; Matsumoto M; Ueda H
Neurochem Int; 2009; 54(3-4):215-21. PubMed ID: 19111589
[TBL] [Abstract][Full Text] [Related]
6. cGMP and cGMP-dependent protein kinase I pathway in dorsal root ganglia contributes to bone cancer pain in rats.
Liu S; Zhang MY; Chen LP; Liu YP; Liu GJ
Spine (Phila Pa 1976); 2014 Sep; 39(19):1533-41. PubMed ID: 24921837
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid as the initiator of neuropathic pain.
Ueda H
Biol Pharm Bull; 2011; 34(8):1154-8. PubMed ID: 21804198
[TBL] [Abstract][Full Text] [Related]
8. P2Y1 purinoceptor inhibition reduces extracellular signal-regulated protein kinase 1/2 phosphorylation in spinal cord and dorsal root ganglia: implications for cancer-induced bone pain.
Chen J; Wang L; Zhang Y; Yang J
Acta Biochim Biophys Sin (Shanghai); 2012 Apr; 44(4):367-72. PubMed ID: 22349022
[TBL] [Abstract][Full Text] [Related]
9. Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain.
Lin ME; Rivera RR; Chun J
J Biol Chem; 2012 May; 287(21):17608-17617. PubMed ID: 22461625
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain.
Ma L; Uchida H; Nagai J; Inoue M; Chun J; Aoki J; Ueda H
Mol Pain; 2009 Nov; 5():64. PubMed ID: 19912636
[TBL] [Abstract][Full Text] [Related]
11. Enhanced function of TRPV1 via up-regulation by insulin-like growth factor-1 in a rat model of bone cancer pain.
Li Y; Cai J; Han Y; Xiao X; Meng XL; Su L; Liu FY; Xing GG; Wan Y
Eur J Pain; 2014 Jul; 18(6):774-84. PubMed ID: 24827675
[TBL] [Abstract][Full Text] [Related]
12. Enhanced SCN7A/Nax expression contributes to bone cancer pain by increasing excitability of neurons in dorsal root ganglion.
Ke CB; He WS; Li CJ; Shi D; Gao F; Tian YK
Neuroscience; 2012 Dec; 227():80-9. PubMed ID: 23026072
[TBL] [Abstract][Full Text] [Related]
13. Rho/ROCK acts downstream of lysophosphatidic acid receptor 1 in modulating P2X3 receptor-mediated bone cancer pain in rats.
Wu JX; Yuan XM; Wang Q; Wei W; Xu MY
Mol Pain; 2016; 12():. PubMed ID: 27094551
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic acid propagates post-injury Schwann cell dedifferentiation through LPA
Szepanowski F; Szepanowski LP; Mausberg AK; Kleinschnitz C; Kieseier BC; Stettner M
Neurosci Lett; 2018 Jan; 662():136-141. PubMed ID: 29051083
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of acid-sensing ion channel 3 within dorsal root ganglia in a rat model of bone cancer pain.
Qiu F; Wei X; Zhang S; Yuan W; Mi W
Neuroreport; 2014 Aug; 25(12):887-93. PubMed ID: 25006846
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of tetrodotoxin-resistant sodium channels Nav1.8 and Nav1.9 within dorsal root ganglia in a rat model of bone cancer pain.
Qiu F; Jiang Y; Zhang H; Liu Y; Mi W
Neurosci Lett; 2012 Mar; 512(2):61-6. PubMed ID: 22342308
[TBL] [Abstract][Full Text] [Related]
17. Activation of TRESK channels by the inflammatory mediator lysophosphatidic acid balances nociceptive signalling.
Kollert S; Dombert B; Döring F; Wischmeyer E
Sci Rep; 2015 Jul; 5():12548. PubMed ID: 26224542
[TBL] [Abstract][Full Text] [Related]
18. Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling.
Inoue M; Rashid MH; Fujita R; Contos JJ; Chun J; Ueda H
Nat Med; 2004 Jul; 10(7):712-8. PubMed ID: 15195086
[TBL] [Abstract][Full Text] [Related]
19. Loss of spinal substance P pain transmission under the condition of LPA1 receptor-mediated neuropathic pain.
Inoue M; Yamaguchi A; Kawakami M; Chun J; Ueda H
Mol Pain; 2006 Aug; 2():25. PubMed ID: 16914035
[TBL] [Abstract][Full Text] [Related]
20. Brain-derived neurotrophic factor modulates N-methyl-D-aspartate receptor activation in a rat model of cancer-induced bone pain.
Wang LN; Yang JP; Ji FH; Zhan Y; Jin XH; Xu QN; Wang XY; Zuo JL
J Neurosci Res; 2012 Jun; 90(6):1249-60. PubMed ID: 22354476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
